0000899243-17-015162.txt : 20170602
0000899243-17-015162.hdr.sgml : 20170602
20170602163019
ACCESSION NUMBER: 0000899243-17-015162
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170531
FILED AS OF DATE: 20170602
DATE AS OF CHANGE: 20170602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLES N ANTHONY
CENTRAL INDEX KEY: 0001197018
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 17888356
MAIL ADDRESS:
STREET 1: MORRIS CORP. CENTER I; BLDG. B; 4TH FLR.
STREET 2: 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-31
0
0001674416
CRISPR Therapeutics AG
CRSP
0001197018
COLES N ANTHONY
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
13.62
2017-05-31
4
A
0
15000
0.00
A
2027-05-31
Common Shares
15000
15000
D
This option was granted on May 31, 2017 with respect to 15,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning June 30, 2017.
/s/ Michael Esposito, attorney-in-fact
2017-06-02